(2E)-3-(Dimethylamino)-1-(3-pyridinyl)-2-propen-1-one
- CAS
- 123367-26-0
- Formula
- C10H12N2O
- MW
- 176.21 g/mol
In stock
Impurity reference standards
Nilotinib impurities & reference standards
Characterised Nilotinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
72reference materials
1nitrosamine impurities
3isotope-labelled
COAHPLC · NMR · MS on request
(E)-3-(Dimethylamino)-1-(pyridin-2-yl)prop-2-en-1-one
- CAS
- 123367-25-9
- Formula
- C10H12N2O
- MW
- 176.21 g/mol
VQ-038642
(Z)-3-(Dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one
- CAS
- 75415-01-9
- Formula
- C10H12N2O
- MW
- 176.21 g/mol
VQ-038645
3 (2- Ethyl-1H imidazole-1yl-)- -5 (Trifluromethyl) aniline
- CAS
- 1260802-16-1
- Formula
- C12H12F3N3
- MW
- 255.24 g/mol
VQ-044827
3-(1H-Imidazol-1-yl)-5-(trifluoromethyl)aniline
- CAS
- 943320-48-7
- Formula
- C10H8F3N3
- MW
- 227.19 g/mol
VQ-023258
3-(2-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline
- CAS
- 641571-06-4
- Formula
- C11H10F3N3
- MW
- 241.21 g/mol
VQ-026909
3-(2,4-Dimethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline
- CAS
- 2119583-28-5
- Formula
- C12H12F3N3
- MW
- 255.24 g/mol
VQ-044582
3-(4-Ethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline
- CAS
- 2119583-27-4
- Formula
- C12H12F3N3
- MW
- 255.24 g/mol
In stock
3-(4-Ethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline Hydrochloride
- Formula
- C12H12F3N3.ClH
- MW
- 291.7 g/mol
VQ-012999
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzamide
- CAS
- 917391-28-7
- Formula
- C12H10F3N3O
- MW
- 269.22 g/mol
VQ-044167
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzoic acid
- CAS
- 641571-13-3
- Formula
- C12H9F3N2O2
- MW
- 270.21 g/mol
In stock
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile
- CAS
- 641571-12-2
- Formula
- C12H8F3N3
- MW
- 251.21 g/mol
VQ-044166
3-(4-Methyl-1H-imidazol-1-yl)-5-trifluoromethylaniline-d3
- CAS
- 1246815-34-8
- Formula
- C11H10F3N3
- MW
- 244.23 g/mol
VQ-049249
3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzoic Acid
- CAS
- 641571-18-8
- Formula
- C12H9F3N2O2
- MW
- 270.21 g/mol
VQ-038643
![3-[(Aminoiminomethyl)amino]-4-methylbenzoic Acid Ethyl Ester Mononitrate chemical structure](/media/structures/YQMZYKJPGMVZJL-UHFFFAOYSA-N.svg)
3-[(Aminoiminomethyl)amino]-4-methylbenzoic Acid Ethyl Ester Mononitrate
- CAS
- 641569-96-2
- Formula
- C11H16N4O5
- MW
- 284.27 g/mol
VQ-038640
3-Amino-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide
- CAS
- 915711-42-1
- Formula
- C19H17F3N4O
- MW
- 374.4 g/mol
VQ-026908
4-methyl-3-((4-(pyridin-2-yl)pyrimidin-2-yl)amino)benzoic acid
- CAS
- 2244129-60-8
- Formula
- C17H14N4O2
- MW
- 306.32 g/mol
In stock
4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide
- CAS
- 851137-91-2
- Formula
- C17H15N5O
- MW
- 305.33 g/mol
VQ-032155
4-methyl-3-((4-(pyridin-4-yl)pyrimidin-2-yl)amino)benzoic acid
- CAS
- 2244129-62-0
- Formula
- C17H14N4O2
- MW
- 306.32 g/mol
In stock
4-Methyl-N-(3-(2-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide
- CAS
- 641571-05-3
- Formula
- C28H22F3N7O
- MW
- 529.5 g/mol
VQ-032159
4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-2-yl)pyrimidin-2-yl)amino)benzamide
- CAS
- 2244128-96-7
- Formula
- C28H22F3N7O
- MW
- 529.52 g/mol
In stock
4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-4-yl)pyrimidin-2-yl)amino)benzamide
- CAS
- 2244128-97-8
- Formula
- C28H22F3N7O
- MW
- 529.5 g/mol
In stock
4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-nitrobenzamide
- CAS
- 1157857-29-8
- Formula
- C19H15F3N4O3
- MW
- 404.3 g/mol
VQ-035209
FAQs — Nilotinib impurities
Which Nilotinib impurities do you supply?
We list 72 Nilotinib-related reference materials, including process impurities, degradation products, nitrosamine impurities, stable-isotope-labelled standards and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Nilotinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Nilotinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Nilotinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.